We recast our Merger and Acquisition (M&A) screen following a record year in 2021 for listed M&A, where close to 10% S&P/ASX 200 market cap was involved in M&A. Our work highlights that close to 20% of S&P/ASX 100 companies could potentially look financially attractive to an acquirer. This includes companies like; Amcor (AMC), Ansell (ANN), Atlas Arteria (ALX), Aurizon (AZJ), Downer EDI (DOW), and Medibank (MPL).
Another conclusion of our work is that investors are currently overlooking value across a broad section of the market. This is despite the upward move in both government and corporate bond yields this year. It may take M&A activity to highlight this value to the broader market, but it is another way to suggest that the market still offers some reasonable value at current levels.
Our list of vulnerable names to M&A all generate enough earnings and cash flow that they would effectively be ‘self-funding’ for an acquirer. That could potentially take the form of a public to public transaction like Home Co Daily Needs REIT (HDN) for Aventus (AVN) 2021, or public to private like we saw with Sydney Airports (SYD) in 2021 and more recently with the rejected proposal for AGL Energy (AGL) last month. In this report we cover:
About Wilsons Advisory: Wilsons Advisory is a financial advisory firm focused on delivering strategic and investment advice for people with ambition – whether they be a private investor, corporate, fund manager or global institution. Its client-first, whole of firm approach allows Wilsons Advisory to partner with clients for the long-term and provide the wide range of financial and advisory services they may require throughout their financial future. Wilsons Advisory is staff-owned and has offices across Australia.
Disclaimer: This communication has been prepared by Wilsons Advisory and Stockbroking Limited (ACN 010 529 665; AFSL 238375) and/or Wilsons Corporate Finance Limited (ACN 057 547 323; AFSL 238383) (collectively “Wilsons Advisory”). It is being supplied to you solely for your information and no action should be taken on the basis of or in reliance on this communication. To the extent that any information prepared by Wilsons Advisory contains a financial product advice, it is general advice only and has been prepared by Wilsons Advisory without reference to your objectives, financial situation or needs. You should consider the appropriateness of the advice in light of your own objectives, financial situation and needs before following or relying on the advice. You should also obtain a copy of, and consider, any relevant disclosure document before making any decision to acquire or dispose of a financial product. Wilsons Advisory's Financial Services Guide is available at wilsonsadvisory.com.au/disclosures.
All investments carry risk. Different investment strategies can carry different levels of risk, depending on the assets that make up that strategy. The value of investments and the level of returns will vary. Future returns may differ from past returns and past performance is not a reliable guide to future performance. On that basis, any advice should not be relied on to make any investment decisions without first consulting with your financial adviser. If you do not currently have an adviser, please contact us and we would be happy to connect you with a Wilsons Advisory representative.
To the extent that any specific documents or products are referred to, please also ensure that you obtain the relevant disclosure documents such as Product Disclosure Statement(s), Prospectus(es) and Investment Program(s) before considering any related investments.
Wilsons Advisory and their associates may have received and may continue to receive fees from any company or companies referred to in this communication (the “Companies”) in relation to corporate advisory, underwriting or other professional investment services. Please see relevant Wilsons Advisory disclosures at www.wilsonsadvisory.com.au/disclosures.
John is a leading investment strategist with 20 years experience.